High-risk acute myeloid leukemia
Clinical trials for High-risk acute myeloid leukemia explained in plain language.
Never miss a new study
Get alerted when new High-risk acute myeloid leukemia trials appear
Sign up with your email to follow new studies for High-risk acute myeloid leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to stop blood cancer relapse after transplant
Disease control Recruiting nowThis study tests whether adding the targeted drug venetoclax to standard chemotherapy before a stem cell transplant can help prevent cancer from returning in people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). About 138 participants aged 12 to 6…
Matched conditions: HIGH-RISK ACUTE MYELOID LEUKEMIA
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New immune cell boost may shield kids from Post-Transplant infections
Disease control Recruiting nowThis study tests whether adding memory immune cells (CD45RO) to a stem cell transplant can help children fight off dangerous viral and fungal infections after the procedure. The transplant uses donor stem cells that have been stripped of certain cells to prevent graft-versus-host…
Matched conditions: HIGH-RISK ACUTE MYELOID LEUKEMIA
Phase 1/2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can supercharged immune cells stop leukemia from returning?
Disease control Recruiting nowThis study tests whether infusing special immune cells called γδ T cells can prevent relapse in people with high-risk acute myeloid leukemia (AML) who have had a stem cell transplant. The trial will enroll 40 adults aged 18 to 65. The main goal is to see if the treatment improves…
Matched conditions: HIGH-RISK ACUTE MYELOID LEUKEMIA
Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a smartphone app improve quality of life for blood cancer patients?
Symptom relief Recruiting nowThis study tests a digital app called DREAMLAND designed to improve quality of life and emotional well-being for adults with acute myeloid leukemia (AML) undergoing intensive chemotherapy. About 200 hospitalized patients will either use DREAMLAND or a standard wellness app. Resea…
Matched conditions: HIGH-RISK ACUTE MYELOID LEUKEMIA
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC